Unconventional therapies for cancer: 5. Vitamins A, C and E

CMAJ. Canadian Medical Association Journal

Volumn 158, Issue 11, 1998, Pages 1483-1488

  Kaegi, Elizabeth ^a   Schneider, Marilyn ^b  

^a Societe canadienne du cancer   (Canada)

^b Can Breast Cancer Res Initiative   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; FENRETINIDE; RETINOL;

BREAST CANCER; CANCER; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOTOXICITY; DESQUAMATION; DIARRHEA; DIETARY INTAKE; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GASTRITIS; HEADACHE; HEARTBURN; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIORAL DERMATITIS; PIGMENT DISORDER; PRURITUS; RASH; REVIEW; UTERINE CERVIX CANCER; VERTIGO; VISUAL IMPAIRMENT; VOMITING;

EID: 0032474505     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Ziegler RG. Vegetables, fruits, and carotenoids and the risk of cancer. Am J Clin Nutr 1991;53(Suppl):251S-9S.
2. Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (part I). Cancer Treat Rep 1987;71(4):391-405.
3. Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (part II). Cancer Treat Rep 1987;71(5):493-515.
4. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201-8.
5. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334(18):1150-5.
6. Moriguchi S, Kishino Y. In vitro activation of tumoricidal properties of human monocytes by beta-carotene encapsulated in liposomes. Nutr Res 1990;10:837-46.
7. Brevard PB. Beta-carotene increases monocyte numbers in peripheral rat blood. Int J Vitam Nutr Res 1993;63:21-5.
8. Bendich A. Beta-carotene and the immune response [review]. Proc Nutr Soc 1991;50:263-74.
9. Santamaria L, Bianchi-Santamaria A. Carotenoids and vitamin A in prevention, adjuvant cancer therapy, mastalgia treatment and AIDS-related complex. In: Carotenoids in human health. Ann N Y Acad Sci 1993;691:255-8.
10. Frey JR, Peck R, Bollag W. Antiproliferative activity of retinoids, interferon alpha and their combination in five human transformed cell lines. Cancer Lett 1991;57:223-7.
11. Baumann KH, Clarke R. Effects of all-trans retinoic acid on proliferation and gene expression of human breast cancer cells in vitro [abstract 1643]. Proc Am Assoc Cancer Res 1994;35:275.
12. Cobleigh MA. Breast cancer and fenretinide, an analogue of vitamin A. Leukemia 1994;8(Suppl 3):S59-S63.
13. Warrel RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324(20):1385-93.
14. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992;3:513-26.
15. Cornic M, Agadir A, Degos L, Chomienne C. Retinoids and differentiation treatment: a strategy for treatment in cancer. Anticancer Res 1994; 14(6A):2339-46.
16. Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol 1992;10(5):839-64.
17. Michat L, Schleuniger U. Foreword. In: Proceedings of the 2nd Workshop on Retinoids in Oncology. London, United Kingdom, January 21-22, 1994. Leukemia 1994;8(Suppl 3):S1.
18. Lacroix A, Bhat PV, Karabatsos A, Couture P, Latreille J, Beaulieu R, et al. Plasma levels of retinol in cancer patients supplemented with retinol. Oncology 1987;44:108-14.
19. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, et al. 13-cis-retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992;84(4):241-5.
20. Rustin GJ. Therapy of solid tumour with retinoids, monotherapy and combination therapy [abstract 202]. Eur J Cancer 1992;29A(Suppl 6):S42.
21. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11(7):1216-22.
22. Sauberlich HE. Pharmacology of vitamin C. Annu Rev Nutr 1994;14:371-91.
23. Alcain FJ, Buron MI. Ascorbate on cell growth and differentiation [review]. J Bioenerg Biomembr 1994;26(4):393-8.
24. Merill AH, Foltz AT, McCormick DB. Vitamins and cancer. In: Alfin-Slater RB, Kritchevsky D, editors. Cancer and nutrition. New York: Plenum Press; 1991, p. 261-320.
25. Bendich A, Langseth L. The health effects of vitamin C supplementation: a review. J Am Coll Nutr 1995;14(2):124-36
26. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 1978;75(9):4538-42.
27. Cameron E, Pauling L. Ascorbic acid as a therapeutic agent in cancer. J Int Acad Prev Med 1979;5(1):8-29.
28. Cameron E, Pauling L, Leibovitz, B. Ascorbic acid and cancer: a review. Cancer Res 1979;39:663-81.
29. Cameron E, Pauling L. Cancer and vitamin C. Menlo Park (CA): Warner Books; 1979.
30. Gershoff SN. Vitamin C (ascorbic acid): New roles, new requirements? Nutr Rev 1993;51(11):313-26.
31. Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA. Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses 1995;44:207-13.
32. Cameron E, Campbell A. The orthomolecular treatment of cancer: II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 1974;9:285-315.
33. Cameron E. Protocol for the use of vitamin C in the treatment of cancer. Med Hypotheses 1991;36:190-4.
34. Diplock AT. Safety of antioxidant vitamins and beta-carotene. Am J Clin Nutr 1995;62(Suppl):1510S-6S.
35. Meadows GG, Pierson HF, Abdallah RM. Ascorbate in the treatment of experimental transplanted melanoma. Am J Clin Nutr 1991;54(Suppl):1284S-91S.
36. Prasad KN. Modulation of the effects of tumor therapeutic agents by vitamin C. Life Sci 1980;27(4):275-80.
37. Tsao CS. Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts. Am J Clin Nutr 1991;54(Suppl):1224S-80S.
38. Leung PY, Miyashita K, Young M, Tsao CS. Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res 1993;13:475-80.
39. Henson DE, Block G, Levine M. Ascorbic and biologic functions and relation to cancer. J Natl Cancer Inst 1991;83(2):347-50.
40. Barinaga M. Vitamin C gets a little respect. Science 1991;254:374-6.
41. Shimpo K, Nagatsu T, Yamada K, Sato T, Niimi H, Shamoto M, et al. Ascorbic acid and adriamycm toxicity. Am J Clin Nutr 1991;54(Suppl):1298S-301S.
42. Jackson JA, Riordan HD, Hunninghake RE, Riordan N. High dose intravenous vitamin C and long term survival of a patient with cancer of the head of the pancreas. J Orthomol Med 1995;10(2):87-8.
43. Riordan N, Jackson JA, Riordan HD. Intravenous vitamin C in a terminal cancer patient. J Orthomol Med 1996;11(2):80-2.
44. Jaffey M. Vitamin C and cancer: examination on the Vale of Leven trial results using broad inductive reasoning. Med Hypothesis 1982;8:49-84.
45. Creagan ET, Moertel CG, O'Fallon JR, Schurt AI, O'Connell MJ, Rubin J, et al. Failure of high-dose vitamin C(ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med 1979;301(13):687-90.
46. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med 1985;312(3):137-41.
47. Wittes RE, Vitamin C and cancer. N Engl J Med 1985;312(3):178-9.
48. Knekt P. Role ot vitamin E in the prophylaxis of cancer. Ann Med 1991;23:3-12.
49. Bieri JG, Corash L, Hubbard VS. Medical uses of vitamin E N Engl J Med 1983;308(18):1063-71.
50. Trickler D, Shklar G. Prevention by vitamin E of experimental oral carcinogenesis. J Natl Cancer Inst 1987;78(1):165-9.
51. Meydani M, Vitamin E. Lancet 1995;345:170-175.
52. Tengerdy RP. The role of vitamin E in immune response and disease resistance. Ann N Y Acad Sci 1990;587:24-33.
53. Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, et al. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst 1993;85(1):44-7.
54. Kline K, Charpentier A, Zhao B, Israel K, Simmons-Menehaca M, Sanders BG. In vitro treatment of human breast cancer cells with RRR-alpha-tocopheryl succinate (vitamin E succinate) inhibits proliferation and enhances the secretion of biologically active transforming growth factor-beta (TGF-Beta) [abstract 1641]. Proc Am Assoc Cancer Res 1994;(35):275.
55. ElAttar TM, Lin HS. Effect of vitamin C and vitamin E on prostaglandin synthesis by fibroblasts and squamous carcinoma cells. Prostaglandins Leukot Essent Fatty Acids 1992;47:253-7.
56. Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery 1990;107:549-51.
57. Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses ot vitamin C and other nutrients with similar patients not receiving these doses. J Orthomol Med 1993;8(3):157-67.
58. Poydock ME. Effect of combined ascorbic acid and B-12 on survival of mice with implanted Ehrlich carcinoma and 1,1210 leukemia. Am J Clin Nutr 1991;54(Suppl):1261S-5S.
59. Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving those doses. J Orthomol Med 1990;5(3):143-54.
60. Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in high risk patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 1994; 15(Suppl):S231-40.
61. Lupulescu A. The role of vitamins A, β-carotene, E and C in cancer cell biology. Int J Vitam Nutr Res 1993;63:3-14.